SECTION 1: SOCIO-DEMOGRAPHIC DATA

1

SEX: M = Male, F = Female

|_|

2

Age (in years)

3

Marital status: S = single, M = married, D = Divorced

|_|

4

Residence

5

Region of origin: EN = Extreme North, N = North, A = Adamawa, C = Centre, W = west, NW = North west, SW = South west, E = East, L = Littoral

|_|

6

Profession

SECTION 2: PAST MEDICAL AND FAMILY HISTORY

7

Chronic pathologies: Y = Yes, N = No

|_|

8

If yes, what type; HTN, diabetes = D, Nephropathy = N, Endocrinopathy = Endoc to precise, Neoplasia = precise, Others (precise)

|_|

9

Use of Medications Y = Yes, N = No

|_|

10

Past surgery Y = Yes, N = No

|_|

11

If yes, precise

|_|

12

Smoking Active = A, passive = P, Non = N

|_|

13

Alcohol comsuption Y = Yes, N = No

|_|

14

If yes, IE = number × volume × % × alcohol density/day

|_|

15

Sedentary life style Y = Yes, N = No

|_|

16

Socio-professional stress Y = Yes, N = No

|_|

17

Similar cas in family, Y = Yes, N = No

|_|

18

Phaeochromocytoma, Y = Yes, N = No

|_|

19

Thyroid medullary carcinoma, Y = Yes, N = No

|_|

20

MEN type I Y = Yes, N = No

|_|

21

Von Hipple—Lindau disease Y = Yes, N = No

|_|

22

Neurofibromatosis Y = Yes, N = No

|_|

23

Other tumor Y = Yes, N = No

|_|

24

If yes precise

|_|

SECTION 3: CLINICAL EXAMINATION

A-Functional Signs

25

Presenting complaint or circumstance of diagnosis

26

Duration of evolution since presentation of first symptom

27

Weight gain Yes |_|, No |_|

|_|

28

Secondary ammenorrhoea Yes |_|, No |_|

|_|

29

Decrease libido Yes |_|, No |_|

|_|

30

Bone signs (non mechanical lumbar or pelvic pains) Yes |_|, No |_|

|_|

31

Immunity disorders Yes |_|, No |_|

|_|

32

Psychiatric disorders/problems Yes |_|, No |_|

|_|

33

HTN Yes |_|, No |_|

|_|

34

Neuromuscular signs Yes |_|, No |_|

|_|

35

Constipation Yes |_|, No |_|

|_|

36

PUPD syndrome Yes |_|, No |_|

|_|

37

Cramps and paresthesia of extremeties Yes |_|, No |_|

|_|

38

Dyspnea on effort Yes |_|, No |_|

|_|

39

Intense pulsatile headache Yes |_|, No |_|

|_|

40

Palpitations Yes |_|, No |_|

|_|

41

Profuse sweating Yes |_|, No |_|

|_|

42

Orthostatique hypotension

|_|

43

Ascending constrictive pains:abdomen and thorax Yes |_|, No |_|

|_|

B-Physical Signs

44

General state: performance status index (WHO)

………

45

Blood pressure

……mm/Hg

46

Pulse

……….Bpm

47

Respiratory rate

………cpm

48

Temperature

……..˚C

49

BMI: weight………(Kg)/Height…….(m)

|_| |_|kg/m2

50

Waist circumference

…..cm

51

Facial and trunkal obesity Yes |_|, No |_|

|_|

52

Easy bruising Yes |_|, No |_|

|_|

53

Cutaneous eruptions (pupural at pertechies) Yes |_|, No |_|

|_|

54

Signs of virilism Yes |_|, No |_|

|_|

55

Amyotrophie of lower limbs Yes |_|, No |_|

|_|

56

Pseudoparalytic crises Yes |_|, No |_|

|_|

57

Cardiac arrhythmias Yes |_|, No |_|

|_|

58

Gynaecomastia Yes |_|, No |_|

|_|

59

Palpable tumour at the level of the abdomen

|_|

60

Presence of goiter, exolpthalmos and signes of thyroid dysfunction Yes |_|, No |_|

|_|

61

Gallactorrhoea Yes |_|, No |_|

|_|

62

Presence of breast nodule Yes |_|, No |_|

|_|

63

Peculiarities of rest of physical examination

……………………………………………………………………………………

……………………………………………………………………………………

……………………………………………………………………………………

SECTION 4: BIOLOGICAL INVESTIGATIONS

Investigation

Results

Normal value

Aldosterone

Plasma renin activity

24 hrs CLU

Freinage minute test

● Midnight cortisol

● 8 h cortisol

ACTH

DHEAS

Testosterone

17OHP

Plasma metanephrines

24 hrs urinary metanephrines

Creatinnuria

Creatinine (mg/l)

Urea (g/l)

FBS

Na+/K+/Cl (meq/l)

Ca2+/PO4/Mg2+

Albuminemia (g/l)

EPPS

TSH (IU/l)

Free T4 pmol/L

CT/HDL/LDL/TG (g/l)

FBC, WBC

Hb

Platelets

CRP

ASAT/ALAT/GGT

Abdominal ultrasound……………………………………………………………………….

…………………………………………………………………………………………………

…………………………………………………………………………………………………

Abdominal CT scan:

● Tumour location: left |_|, right |_|

● Size of tumour: ……….cm

● Content: homogenous |_|, heterogeneous|_|

● Spontaneous density: <10 HU |_|, >10 HU |_|

● Wash out: absolute……..%, Relative…………….%

● Limits: Regular irregular

● Necrosis: Yes |_|, No |_|

● Calcifications: Yes |_|, No |_|

● Infiltration of pararenal fats: Yes |_|, No |_|

● Hemorrhagic Yes |_|, No |_|

● Metastasis Yes |_|, No |_|

Chest X-Ray:………………………………………………………………………………….

Others: ………………………………………………………………………………………..

SECTION 6: SURGICAL MANAGEMENT

A-Pre-surgical preparation

Pre-anesthetic consultation: ASA………………, Altemier

Pre-surgical investigations:

FBC, WBC

Hb

Platelets, TP TCK

Urea creatinine

64

Multidispinary consertations (RCP) Yes |_|, No |_|

65

Medications Yes |_|, No |_|

66

If yes which type of medications?

67

Blood transfusion Yes |_|, No |_|

B-Per operative

Day of surgical intervention……………………………………………………

Duration with respect to onset of symptoms

Type of Anesthesia:……………………………………………

Installation of patient:………………………………………….

68

Indications:

69

Type of surgical intervention: Laparoscopic open surgery

70

Surgical technic: 1-Total adrenalectomy, 2-Partial adrenalectomy,

71

Surgical approach: 1-anterior midline, 2-Anterior Subcostal, 3-Anterior bisubcostal

4-thoracoabdominal

72

Surgical attitude: 1 = transperitoneal, 2 = extraperitoneal

73

Intraoperative findings:

74

Per-operative complications:

HTN: Yes |_|, No |_|

Hypotension Yes |_|, No |_|

Bleeding Yes |_|, No |_|

Cardiac arrest Yes |_|, No |_|

Peritoneal breech Yes |_|, No |_|

Pleural effraction Yes |_|, No |_|

IVC injury Yes |_|, No |_|

Adjacent organ injury Yes |_|, No |_|

75

Duration of surgery:

76

Specimen size………(cm) and weight……..(g)

C-Post surgery

77

Immediate

…………………………………………………………………………………………

…………………………………………………………………………………………

78

Complications:

Hemorrhage: Yes |_|, No |_|

Anemia: Yes |_|, No |_|

Surgical site infection: Yes |_|, No |_|

Acute adrenal insufficiency: Yes |_|, No |_|

Paralytic ileus: Yes |_|, No |_|

Fistulas: Yes |_|, No |_|

Death: Yes |_|, No |_|

Others

79

hospital stay duration

SECTION 7: DIAGNOSIS (Anatomopathological diagnosis)

80

Anatomopathological results:…………………………………………………………

………………………………………………………………………………………….

SECTION 8: ADJUVANT TREATMENT

Hydrocortisone supplementation Yes |_|, No |_|

Chemotherapy Yes |_|, No |_|

SECTION 9: SURVEILLANCE

81

CLINICAL:

Resolution of initial clinical signs Yes |_|, No |_|

Appearance of new signs: Yes |_|, No |_|

……………………………………………………………….

…………………………………………………………………………………………

Relapse

82

Paraclinical:

● Cortisol 8 h

● Cortisol 1 H after synacthene test

Base 0 - 3 months 3 - 6 months >6 m

83

Control abdominal CT scan